Zhejiang Qizheng Pharmaceutical

Zhejiang Qizheng Pharmaceutical, also known as Kisun Pharmaceutical, is a subsidiary of Zhejiang Ausun Pharmaceutical specializing in the research, development, and manufacturing of high-quality pharmaceutical formulations. Based in Taizhou, China, the company operates state-of-the-art facilities that have received both Chinese and European GMP certifications. Its product portfolio includes a range of generic and innovative drugs in solid oral and injectable forms, with a focus on therapeutic areas such as oncology, infectious diseases, and metabolic disorders. Notable products include Imatinib Mesylate tablets, which are exported to European markets, and Sitafloxacin tablets, which recently received Chinese regulatory approval. The company also provides CDMO and CRO services, collaborating with international partners like STADA and Algernon Pharmaceuticals.